Federated Hermes Q4 EPS $0.96, record AUM $757.6B; dividend $0.28

FEDERATED HERMES, INC.

2023-FY EPS reported $3.40 revenue$1,609,574,000

Q4 2023 EPS of $0.96 (diluted) vs. $0.63 in Q4 2022; net income $82.2M vs. $56.5M.
Full-year 2023 EPS $3.40 vs. $2.65; net income $299.0M up from $239.5M.
Total AUM hit record $757.6B at Dec. 31, 2023, up 13% YoY and 6% QoQ.
Board declared $0.28 quarterly dividend, payable Feb. 15, 2024 to holders of record Feb. 8.
Q4 share repurchases: 1.9M shares for $61.0M; full-year 5.3M shares for $178.0M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

FEDERATED HERMES, INC. reported full-year 2023 results: net income net income of $299.0 million for 2023, EPS full-year 2023 EPS of $3.40.

Period: full-year 2023
Net income: net income of $299.0 million for 2023
EPS: full-year 2023 EPS of $3.40
Result: reported results

Exact text from the filing

Full-year 2023 EPS was $3.40, compared to $2.65 for 2022 on net income of $299.0 million for 2023, compared to $239.5 million for 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

FEDERATED HERMES, INC. reported Q4 2023 results: net income net income of $82.2 million for Q4 2023, EPS Q4 2023 earnings per diluted share of $0.96.

Period: Q4 2023
Net income: net income of $82.2 million for Q4 2023
EPS: Q4 2023 earnings per diluted share of $0.96
Result: reported results

Exact text from the filing

Federated Hermes, Inc. reports fourth quarter and full-year 2023 earnings • Q4 2023 earnings per diluted share of $0.96; full-year 2023 EPS of $3.40

View on SEC.gov

Browse all earnings releases →

FEDERATED HERMES, INC. filing history →

Source: SEC EDGAR

accession 0001056288-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.